VeriMombuxus sempervirens leaf extract hamilelikte güvenli mi?
No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
Related ingredients
Frequently asked questions
- buxus sempervirens leaf extract hamilelikte güvenli mi?
- No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
- buxus sempervirens leaf extract emzirirken güvenli mi?
- Same evidence base as for pregnancy: no regulatory bans/restrictions (EU Annex II/III), no harmonised H361/H360 classification, and no breastfeeding‑specific toxicity or transfer data for the cosmetic leaf extract. Ingestion of whole plant is known to be toxic (steroidal alkaloids), but that does not constitute evidence of reproductive/lactation hazard from topical cosmetic use; exposure from dermal use is low but measurable.
- buxus sempervirens leaf extract bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental toxicity data were identified for the cosmetic extract. Because infant skin has a higher surface‑area‑to‑body‑weight ratio and an immature barrier, I increased exposure by +1 relative to the adult dermal exposure score; there is still no evidence of a reproductive mechanism or harmonised classification for the cosmetic ingredient itself.
- VeriMom buxus sempervirens leaf extract nasıl puanlıyor?
- VeriMom buxus sempervirens leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte buxus sempervirens leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.